Reference
Price D, et al. Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting. Respiratory Medicine : 2 Oct 2014. Available from: URL: http://doi.org/10.1016/j.rmed.2014.09.015
Rights and permissions
About this article
Cite this article
Glycopyrrolate/indacaterol a good cost option in COPD. PharmacoEcon Outcomes News 714, 20 (2014). https://doi.org/10.1007/s40274-014-1641-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1641-1